Literature DB >> 26851295

The Emerging Importance of IgG Fab Glycosylation in Immunity.

Fleur S van de Bovenkamp1, Lise Hafkenscheid2, Theo Rispens3, Yoann Rombouts4.   

Abstract

Human IgG is the most abundant glycoprotein in serum and is crucial for protective immunity. In addition to conserved IgG Fc glycans, ∼15-25% of serum IgG contains glycans within the variable domains. These so-called "Fab glycans" are primarily highly processed complex-type biantennary N-glycans linked to N-glycosylation sites that emerge during somatic hypermutation. Specific patterns of Fab glycosylation are concurrent with physiological and pathological conditions, such as pregnancy and rheumatoid arthritis. With respect to function, Fab glycosylation can significantly affect stability, half-life, and binding characteristics of Abs and BCRs. Moreover, Fab glycans are associated with the anti-inflammatory activity of IVIgs. Consequently, IgG Fab glycosylation appears to be an important, yet poorly understood, process that modulates immunity.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26851295     DOI: 10.4049/jimmunol.1502136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  91 in total

Review 1.  Regulation of antibody effector functions through IgG Fc N-glycosylation.

Authors:  Isaak Quast; Benjamin Peschke; Jan D Lünemann
Journal:  Cell Mol Life Sci       Date:  2016-09-17       Impact factor: 9.261

2.  A study of the possible role of Fab-glycosylated IgG in tumor immunity.

Authors:  Qian Xu; Xiaodong Deng; Biying Zhang; Chanyuan Zhao; Tao Huang; Yimin Zhang; Zhiming Chen; Jiang Gu
Journal:  Cancer Immunol Immunother       Date:  2021-01-03       Impact factor: 6.968

3.  Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody.

Authors:  John P Giddens; Joseph V Lomino; David J DiLillo; Jeffrey V Ravetch; Lai-Xi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-05       Impact factor: 11.205

4.  Decreased Immunoglobulin G Core Fucosylation, A Player in Antibody-dependent Cell-mediated Cytotoxicity, is Associated with Autoimmune Thyroid Diseases.

Authors:  Tiphaine C Martin; Mirna Šimurina; Marta Ząbczyńska; Marina Martinic Kavur; Magdalena Rydlewska; Marija Pezer; Kamila Kozłowska; Andrea Burri; Marija Vilaj; Renata Turek-Jabrocka; Milena Krnjajić-Tadijanović; Małgorzata Trofimiuk-Müldner; Ivo Ugrina; Anna Lityńska; Alicja Hubalewska-Dydejczyk; Irena Trbojevic-Akmacic; Ee Mun Lim; John P Walsh; Ewa Pocheć; Tim D Spector; Scott G Wilson; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2020-02-05       Impact factor: 5.911

5.  State-of-the-Art Glycomics Technologies in Glycobiotechnology.

Authors:  Alexander Pralow; Samanta Cajic; Kathirvel Alagesan; Daniel Kolarich; Erdmann Rapp
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

6.  Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region.

Authors:  Fleur S van de Bovenkamp; Ninotska I L Derksen; Pleuni Ooijevaar-de Heer; Karin A van Schie; Simone Kruithof; Magdalena A Berkowska; C Ellen van der Schoot; Hanna IJspeert; Mirjam van der Burg; Ann Gils; Lise Hafkenscheid; René E M Toes; Yoann Rombouts; Rosina Plomp; Manfred Wuhrer; S Marieke van Ham; Gestur Vidarsson; Theo Rispens
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

Review 7.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

8.  One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.

Authors:  Xin Tong; Tiezheng Li; Jared Orwenyo; Christian Toonstra; Lai-Xi Wang
Journal:  Bioorg Med Chem       Date:  2017-07-29       Impact factor: 3.641

Review 9.  Glycan recognition at the saliva - oral microbiome interface.

Authors:  Benjamin W Cross; Stefan Ruhl
Journal:  Cell Immunol       Date:  2018-08-18       Impact factor: 4.868

Review 10.  Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Authors:  Michaela Seeling; Christin Brückner; Falk Nimmerjahn
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.